We are live on ! Find out more
PEAR

Pear Therapeutics, Inc. Class A Common Stock
PEAR

Delisted

PEAR was delisted on the 18th of April, 2023.

Back to rankings

18 hedge funds and large institutions have $26.9M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$6.92M
2
SCM
Saba Capital Management
New York
+$6.42M
3
UOC
UBS O'Connor
Illinois
+$2.41M
4
OCM
Oribel Capital Management
New York
+$2.05M
5
SC
Sculptor Capital
New York
+$1.93M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$6.87M +$6.92M +715,895 New
SCM
2
Saba Capital Management
New York
$6.38M +$6.42M +665,095 New
UOC
3
UBS O'Connor
Illinois
$2.4M +$2.41M +249,991 New
OCM
4
Oribel Capital Management
New York
$2.05M +$2.05M +212,356 New
SC
5
Sculptor Capital
New York
$1.93M +$1.93M +199,998 New
Verition Fund Management
6
Verition Fund Management
Connecticut
$1.74M +$1.75M +181,150 New
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$1.45M +$1.45M +150,000 New
FTCM
8
Fir Tree Capital Management
New York
$959K +$966K +100,000 New
HI
9
HBK Investments
Texas
$676K +$676K +69,948 New
WA
10
Whitebox Advisors
Minnesota
$482K +$486K +50,300 New
CH
11
CVI Holdings
Delaware
$480K +$483K +50,000 New
Goldman Sachs
12
Goldman Sachs
New York
$382K +$382K +39,540 New
Jane Street
13
Jane Street
New York
$241K +$241K +24,900 New
ACM
14
Atalaya Capital Management
New York
$240K +$242K +25,000 New
DCM
15
DG Capital Management
New York
$240K +$242K +25,000 New
VI
16
Vestcor Inc
New Brunswick, Canada
$240K +$242K +25,000 New
OCAM
17
Owl Creek Asset Management
New York
$121K +$121K +12,498 New
BCM
18
Basso Capital Management
Connecticut
$1K +$966 +100 New

PEAR Hedge Fund Activity: Q1 2021 in Review

18 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Class A Common Stock (PEAR) for Q1 2021, worth a combined $26.9M.

Buyers outnumbered sellers: 18 funds opened new PEAR positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $6.92M.

  • 18 institutional investors held Pear Therapeutics, Inc. Class A Common Stock (PEAR) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $26.9M of Pear Therapeutics, Inc. Class A Common Stock stock for Q1 2021.
  • 18 funds opened new Pear Therapeutics, Inc. Class A Common Stock positions in Q1 2021 and 0 closed out, a net change of +18 holders.
  • The largest Pear Therapeutics, Inc. Class A Common Stock buyer in Q1 2021 was Citadel Advisors, an estimated $6.92M added.

Based on aggregated 13F filings for Q1 2021.